Cardiac autonomic dysfunction in type 2 diabetes - effect of hyperglycemia and disease duration

Mika P Tarvainen1, Tomi P Laitinen2, Jukka A Lipponen3

  • 1Department of Applied Physics, University of Eastern Finland , Kuopio , Finland ; Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital , Kuopio , Finland.

Insights

Diabetes mellitus (DM) patients show reduced heart rate variability (HRV), indicating impaired cardiac autonomic regulation. Elevated blood glucose and longer diabetes duration significantly decrease HRV, especially within the first 5-10 years.

Area of Science:

  • Cardiology
  • Endocrinology
  • Autonomic Neuroscience

Background:

  • Diabetes mellitus (DM) is linked to cardiac autonomic dysfunction.
  • Reduced heart rate variability (HRV) in DM patients suggests increased cardiac event risk.

Purpose of the Study:

  • To investigate the association between blood glucose levels (BGL), glycated hemoglobin (HbA1c), and diabetes duration with cardiac autonomic regulation.
  • To assess cardiac autonomic regulation using HRV analysis in type 2 DM (T2DM) patients.

Main Methods:

  • Analysis of resting electrocardiogram (ECG) and clinical data from 189 healthy controls and 93 T2DM patients.
  • HRV assessment using time-domain, frequency-domain, and non-linear methods.
  • Correlation analysis of BGL, HbA1c, and diabetes duration with HRV parameters.

Main Results:

  • Significant differences in HRV parameters were observed between healthy controls and T2DM patients.
  • Hyperglycemia (elevated BGL and HbA1c) correlated with increased heart rate and decreased HRV.
  • Diabetes duration showed a strong association with decreased HRV, most pronounced within 5-10 years of diagnosis.

Conclusions:

  • Elevated blood glucose levels negatively impact cardiac autonomic function in T2DM patients.
  • The detrimental effect of hyperglycemia on cardiac autonomic function is more pronounced in long-term T2DM.
  • Autonomic neuropathy, indicated by significant HRV reduction, is most evident within the first 5-10 years of diabetes progression.

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
42
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
12
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
54
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
18
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
11
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
25